StockData
Fate Therapeutics Inc logo

Fate Therapeutics Inc (FATE) stock

FATENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3024% below fair value
$1.02−0.12 (-10.53%)

Close on Nov 17, 2026Market cap $122.22MP/E –Yield –

Fate Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Fate Therapeutics's market cap was $187.29M on Nov 11, 2026, against $131.48M a year earlier. Over the last 5 years it ranged from $90.01M to $5.58B, with a median of $368.71M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$187.29M+65.3%
2025Dec 31, 2025$113.33M-39.7%
2024Dec 31, 2024$187.91M-49.0%
2023Dec 29, 2023$368.71M-62.4%
2022Dec 30, 2022$979.86M-82.4%
2021Dec 31, 2021$5.58B-29.5%
2020Dec 31, 2020$7.91B+436.0%
2019Dec 31, 2019$1.48B+78.3%
2018Dec 31, 2018$827.58M+226.7%
2017Dec 29, 2017$253.30M+195.5%
2016Dec 30, 2016$85.71M-11.4%
2015Dec 31, 2015$96.77M-6.4%
2014Dec 31, 2014$103.43M+1095.5%
2013Dec 31, 2013$8.65M–

More Fate Therapeutics figures

See a number that looks wrong?